Director Healthy Lifespan and Chronic Diseases Program
School of Health and Biomedical Sciences
RMIT University, Bundoora, Melbourne AustraliaPhD 1995, University of Melbourne, and Austin Research Institute.30 years experience in research in the area of vaccines and drugs for cancer and chronic diseases with translational focus. In addition, extensive clinical research background, translating research to clinical trials. Multidisciplinary research expertise, in the areas of, immunology, crystallography, medicinal chemistry, biochemistry, crystallography, clinical research and drug development. Main focus is treating diseases with an immunological focus.Areas of research include: cancer, infectious diseases, multiple sclerosis, drug addiction, type-1/2/3 diabetes, mental health. Bio-active compounds in health and disease. Understanding disease progression, how the immune system responds to disease and developing ways to overcome disease.Current Professional Activities, Journals:
Editor in Chief, Outbreak Management Response
Regional Editor, Recent Patents Anti-Cancer Drug Discovery
Section Editor, Current Medicinal Chemistry
Regional Editor – Oceana, Medicinal Chemistry
Editor in Chief, Vaccines (section: Toxicology and Clinical trials; section: Clinical Immunology)
Associate Editor, Immunotherapy
Associate Editor, Frontiers in Immunology
Review Editor, Frontiers in Immunotherapies and VaccinesEditorial Advisory Board of Cancers; Maturitas; Frontiers in Microbial Immunology; Expert Review of Vaccines; Acta Biochimica et Biophysica Sinica; Frontiers in Immunotherapies and Vaccines; Biomed Research International (Immunology subject area); Updates in Gynecology and ObstetricsGuest Editor of Expert Review of Vaccines; Journal of Drug Delivery; Molecular Pharmaceutics; Current Pharmaceutical Design; Vaccines; Medicinal Chemistry; Cancers; Vaccines; Brain Sciences; MaturitasJudging Panel for numerous national and international awards
Author of over 500 research publications and book chapters, and an inventor of 20 patents and 90 sub-patents